PBI-1668

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePBI-1668
Drug Alias Nameanticancer therapy (ProMetic)PBI-1668
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLiminal Biosciences Inc
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A